This inventor holds 5 USPTO granted patents and 1 published patent application. Top assignee: University of California. Active years: 2021-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2025
Title: Innovations by Cristina Puig Saus
Introduction
Cristina Puig Saus is a prominent inventor based in Los Angeles, CA. She has made significant contributions to the field of biotechnology, particularly in the area of T cell receptor engineering. With a total of five patents to her name, her work is paving the way for advancements in immunotherapy.
Latest Patents
Among her latest patents is the innovative method for the targeted replacement of endogenous T cell receptors. This patent outlines methods and compositions for editing the genome of human T cells. In some embodiments, a heterologous T cell receptor (TCR)-β chain and a heterologous TCR-α chain are inserted into exon 1 of a TCR subunit constant gene in the genome of the T cell. This groundbreaking work has the potential to enhance the efficacy of T cell therapies.
Career Highlights
Cristina Puig Saus is affiliated with the University of California, where she conducts her research and development. Her academic background and ongoing research contribute to her reputation as a leading figure in her field.
Collaborations
She collaborates with notable colleagues such as Theodore Lee Roth and Eric Shifrut, further enriching her research endeavors and expanding the impact of her innovations.
Conclusion
Cristina Puig Saus is a trailblazer in the field of biotechnology, with her innovative patents and collaborations driving advancements in T cell therapy. Her work exemplifies the potential of targeted genetic engineering in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile